Global Point-Of-Care Diagnostics Market
Point-of-Care Diagnostics Market
According to Verified Market Research, Global Point-of-Care Diagnostics Market was valued at USD 24.26 Billion in 2018 and is projected to reach USD 51.6 Billion by 2026, growing at a CAGR of 9.9% from 2019 to 2026.
Global Point-of-Care Diagnostics Market Outlook
More patients are preferring for Point-Of-Care (POC) diagnosis. The market is anticipated to propel due to several advantages it has to offer such as convenience, reduced patients' waiting time, fewer or no follow-ups, accurate test results, immediate planning for treatment, and improved healthcare delivery. Hospital visits become difficult for the geriatric population and a rise in the geriatric population is helping the market to grow. With such type of diagnosis, the spread of infectious diseases is also brought under control. Growing support from various Governments across the world in rapid diagnosis has helped in market growth. However, lack of awareness and poor progress in developing countries are the biggest restraints in the market.
Global Point-of-Care Diagnostics Market Competitive Landscape
The Global Point-of-Care Diagnostics Market study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Danaher Corporation, Trinity Biotech, Abbott Laboratories, Roche Diagnostics, Accubiotech, EKF Diagnostics.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.